AI assistant
Sending…
Nykode Therapeutics ASA — Director's Dealing 2021
Sep 10, 2021
3695_dirs_2021-09-10_45bab6d1-c2d9-464b-a2d9-35ff5e1cb467.pdf
Director's Dealing
Open in viewerOpens in your device viewer
| 1 | Details of the closely associated enterprise | |||
|---|---|---|---|---|
| a) | Name | Datum Invest AS | ||
| 2 | Details of the person discharging managerial responsibilities | |||
| a) | Name | Jan Haudemann-Andersen | ||
| b) | Position | Board Member | ||
| 3 | Reason for notification | |||
| a) | Initial notification/ Amendment |
Initial | ||
| 4 | Details of issuer | |||
| a) | Name | Vaccibody AS | ||
| b) | LEI | 254900UKQHWYZJD22017 | ||
| 5 | conducted | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been |
||
| a) | Description of the financial instrument, type of instrument |
Shares in Vaccibody AS (ISIN: NO0010714785) | ||
| b) | Nature of the transaction |
Sale of shares to closely associated enterprise | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| NOK 79 | 5,000,000 | |||
| d) | Aggregated information | Price | NOK 79 | |
| -Average price, | Volume | 5,000,000 | ||
| aggregated volume and total amount |
Total amount | NOK 395,000,000 | ||
| e) | Date of the transaction | 10.09.2021 | ||
| f) | Place of the transaction | MERK – Euronext Growth Oslo |
| 1 | Details of the closely associated enterprise | |||
|---|---|---|---|---|
| a) | Name | Datum AS | ||
| 2 | Details of the person discharging managerial responsibilities | |||
| a) | Name | Jan Haudemann-Andersen | ||
| b) | Position | Board Member | ||
| 3 | Reason for notification | |||
| a) | Initial notification/ Amendment |
Initial | ||
| 4 | Details of issuer | |||
| a) | Name | Vaccibody AS | ||
| b) | LEI | 254900UKQHWYZJD22017 | ||
| 5 | conducted | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been |
||
| a) | Description of the financial instrument, type of instrument |
Shares in Vaccibody AS (ISIN: NO0010714785) | ||
| b) | Nature of the transaction |
Sale of shares to closely associated enterprise | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| NOK 79 | 21,000,000 | |||
| d) | Aggregated information | Price | NOK 79 | |
| -Average price, | Volume | 21,000,000 | ||
| aggregated volume and total amount |
Total amount | NOK 1,659,000,000 | ||
| e) | Date of the transaction | 10.09.2021 | ||
| f) | Place of the transaction | MERK – Euronext Growth Oslo |
| 1 | Details of the closely associated enterprise | |||
|---|---|---|---|---|
| a) | Name | Datum Vekst AS | ||
| 2 | Details of the person discharging managerial responsibilities | |||
| a) | Name | Jan Haudemann-Andersen | ||
| b) | Position | Board Member | ||
| 3 | Reason for notification | |||
| a) | Initial notification/ Amendment |
Initial | ||
| 4 | Details of issuer | |||
| a) | Name | Vaccibody AS | ||
| b) | LEI | 254900UKQHWYZJD22017 | ||
| 5 | conducted | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been |
||
| a) | Description of the financial instrument, type of instrument |
Shares in Vaccibody AS (ISIN: NO0010714785) | ||
| b) | Nature of the transaction |
Sale of shares to closely associated enterprise | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| NOK 79 | 2,395,500 | |||
| d) | Aggregated information | Price | NOK 79 | |
| -Average price, | Volume | 2,395,500 | ||
| aggregated volume and total amount |
Total amount | NOK 189,244,500 | ||
| e) | Date of the transaction | 10.09.2021 | ||
| f) | Place of the transaction | MERK – Euronext Growth Oslo |
| 1 | Details of the closely associated enterprise | |||
|---|---|---|---|---|
| a) | Name | Datum Opportunity AS | ||
| 2 | Details of the person discharging managerial responsibilities | |||
| a) | Name | Jan Haudemann-Andersen | ||
| b) | Position | Board Member | ||
| 3 | Reason for notification | |||
| a) | Initial notification/ Amendment |
Initial | ||
| 4 | Details of issuer | |||
| a) | Name | Vaccibody AS | ||
| b) | LEI | 254900UKQHWYZJD22017 | ||
| 5 | conducted | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been |
||
| a) | Description of the financial instrument, type of instrument |
Shares in Vaccibody AS (ISIN: NO0010714785) | ||
| b) | Nature of the transaction |
Acquisition of shares from closely associated enterprise | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| NOK 79 | 26,000,000 | |||
| d) | Aggregated information | Price | NOK 79 | |
| -Average price, | Volume | 26,000,000 | ||
| aggregated volume and total amount |
Total amount | NOK 2,054,000,000 | ||
| e) | Date of the transaction | 10.09.2021 | ||
| f) | Place of the transaction | MERK – Euronext Growth Oslo |
| 1 | Details of the closely associated enterprise | |||
|---|---|---|---|---|
| a) | Name | Datum Finans AS | ||
| 2 | Details of the person discharging managerial responsibilities | |||
| a) | Name | Jan Haudemann-Andersen | ||
| b) | Position | Board Member | ||
| 3 | Reason for notification | |||
| a) | Initial notification/ Amendment |
Initial | ||
| 4 | Details of issuer | |||
| a) | Name | Vaccibody AS | ||
| b) | LEI | 254900UKQHWYZJD22017 | ||
| 5 | conducted | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been |
||
| a) | Description of the financial instrument, type of instrument |
Shares in Vaccibody AS (ISIN: NO0010714785) | ||
| b) | Nature of the transaction |
Acquisition of shares from closely associated enterprise | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| NOK 79 | 2,395,500 | |||
| d) | Aggregated information | Price | NOK 79 | |
| -Average price, | Volume | 2,395,500 | ||
| aggregated volume and total amount |
Total amount | NOK 189,244,500 | ||
| e) | Date of the transaction | 10.09.2021 | ||
| f) | Place of the transaction | MERK – Euronext Growth Oslo |
More from Nykode Therapeutics ASA
Report Publication Announcement
2026
May 18
Report Publication Announcement
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 13
Report Publication Announcement
2026
May 13
Regulatory Filings
2026
May 7
Capital/Financing Update
2026
May 7
Investor Presentation
2026
Apr 30
Investor Presentation
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 21
AGM Information
2026
Apr 21